Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$274.90 USD

274.90
1,518,178

+3.90 (1.44%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $275.00 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (231 out of 244)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here is Why Growth Investors Should Buy Cigna (CI) Now

by Zacks Equity Research

Cigna (CI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Equity Research

What's in the Cards for Assurant (AIZ) This Earnings Season?

by Zacks Equity Research

Assurant's (AIZ) Q3 results are likely to reflect higher claims activity in Connected Living, mobile seasonality and lower mortality risk.

Zacks Equity Research

Prudential (PRU) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Prudential's (PRU) Q3 results are likely to reflect the re-pricing of products and shift toward lower risk and less capital-intensive products.

Zacks Equity Research

Can Cigna (CI) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Cigna (CI) Stock Moves -1.41%: What You Should Know

by Zacks Equity Research

Cigna (CI) closed at $181.88 in the latest trading session, marking a -1.41% move from the prior day.

Zacks Equity Research

Should Value Investors Buy Cigna (CI) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Sweta Killa headshot

Trump or Biden, These Value ETFs & Stocks Are Set to Soar

by Sweta Killa

The historical patterns show that elections have a long track of doing wonders for value stocks.

Zacks Equity Research

Cigna Set to Grab a Bigger Pie of Medicare Advantage Business

by Zacks Equity Research

Cigna's (CI) Medicare Advantage expansion in new counties and states with attractive prices and a suite of product and service offerings holds promise to widen its market share.

Zacks Equity Research

Humana Expands Medicare Plans to Boost New Jersey Footprint

by Zacks Equity Research

Humana's (HUM) 2021 Medicare Advantage plans will not only expand its presence in New Jersey but also provide improved health outcomes.

Zacks Equity Research

Centene's 2021 Medicare Plans to Strengthen U.S. Footprint

by Zacks Equity Research

Centene's (CNC) 2021 health plans will not only expand its presence by 30% in the United States but also provide improved health outcomes for its members.

Zacks Equity Research

Cigna's Acquisitions, Diversified Businesses to Aid Growth

by Zacks Equity Research

Cigna's (CI) expanded business portfolio and favorable cash flow generation to contribute to the stock's prospects.

Zacks Equity Research

Humana (HUM) Offers Medicare Advantage Health Plans for 2021

by Zacks Equity Research

Humana (HUM) unveils 2021 Medicare product offerings and better benefits in more counties across the nation.

Zacks Equity Research

Cigna's 2021 Improved Health Plans to Expand Member Base

by Zacks Equity Research

Cigna's (CI) 2021 health plans with enhanced features will not only expand its presence by 22% in the United States but also provide improved health outcomes.

Zacks Equity Research

UnitedHealth Arm Rolls Out Enhanced Health Plans for 2021

by Zacks Equity Research

UnitedHealth Group's (UNH) unit, UnitedHealthcare, reveals cost-effective health plans for 2021. This is likely to expand the company's U.S. footprint.

Zacks Equity Research

Zacks Value Trader Highlights: Anthem, Cigna Corp, Gray Television, Hibbett Sports and Meritage Homes

by Zacks Equity Research

Zacks Value Trader Highlights: Anthem, Cigna Corp, Gray Television, Hibbett Sports and Meritage Homes

Tracey Ryniec headshot

5 Top Classic Value Stocks

by Tracey Ryniec

It's rare to have cheap classic value fundamentals and the top Zacks Rank. Here's how to screen for them.

Zacks Equity Research

Is Cigna (CI) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Sanghamitra Saha headshot

Bet on Rising P/E With These 5 Top Stocks

by Sanghamitra Saha

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Zacks Equity Research

Uncertainty Over Supreme Court Ruling Weighs on Healthcare

by Zacks Equity Research

Health insurers and hospital stocks depreciate after Justice Ruth Bader Ginsburg who defended the Obamacare breathes her last.

Zacks Equity Research

Here's Why You Should Retain Cigna Stock in Your Portfolio

by Zacks Equity Research

Cigna (CI) is poised for growth, given its continuous efforts to innovate solutions and growing suite of telehealth services.

Zacks Equity Research

Here's What Makes UnitedHealth (UNH) an Attractive Stock

by Zacks Equity Research

United Health's (UNH) prolific business profile, strong market share and a reputed brand name poise it well for long-term growth.

Zacks Equity Research

Cigna (CI) Enhances Offerings in the Individual Exchange

by Zacks Equity Research

Cigna's (CI) health plans with enhanced features will not only expand its customer reach by 27% but also strengthen its presence on the individual exchange.

Zacks Equity Research

Cigna (CI) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Cigna (CI) closed at $178.61 in the latest trading session, marking a +0.1% move from the prior day.

Zacks Equity Research

Cigna and Dignity Health Sign New Deal to Serve Patients

by Zacks Equity Research

Cigna's (CI) collaboration with Dignity Health intends to provide improved health outcomes for the California and Nevada communities.

Zacks Equity Research

Cigna (CI) Up 1.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Cigna (CI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.